Related Experiment Video
Updated: Jul 14, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Management of hydrocephalus in children with plasminogen deficiency
M R Weinzierl1, H Collmann, M C Korinth
1Department of Neurosurgery, Technical University Aachen, Aachen, Germany. m.weinzierl@ukaachen.de
Insights
Congenital plasminogen deficiency can cause hydrocephalus, often worsening prognosis. Ventriculocholecystic shunting may be a superior treatment option for these complex cases.
Area of Science:
- Medical Genetics
- Pediatric Neurology
- Ophthalmology
Background:
- Congenital plasminogen deficiency is a rare disorder typically presenting with ligneous conjunctivitis.
- Associated pseudomembranous lesions can affect various mucosal surfaces.
- Hydrocephalus is an exceptionally rare complication, with limited reported cases.
Observation:
- Two pediatric cases of congenital plasminogen deficiency with hydrocephalus are presented.
- Initial treatment with ventriculoperitoneal (VP) shunts led to recurrent malfunctions due to peritoneal pseudomembranes.
- A ventriculoatrial (VA) shunt in one patient failed due to catheter thrombosis.
Findings:
- Ventriculoperitoneal shunting is often ineffective in plasminogen deficiency due to impaired peritoneal absorption.
- Ventriculoatrial shunting carries a high risk of thrombosis in these patients.
- Ventriculocholecystic shunting proved successful in both presented cases.
Implications:
- Management of hydrocephalus in congenital plasminogen deficiency requires careful consideration of shunt type.
- Ventriculocholecystic shunting should be considered early to avoid VP shunt failure and VA shunt complications.
- This approach may improve outcomes for children with this rare comorbidity.
Abstract:
Congenital plasminogen deficiency is an infrequent disorder, which usually becomes symptomatic as ligneous conjunctivitis. However, pseudomembranous lesions in the mucosa of the pharynx, tracheobronchial tree, and the peritoneum may likewise occur. An accompanying hydrocephalus is extremely rare; only 16 cases have been reported to date. The reports indicate that hydrocephalus, even if treated by ventriculoperitoneal (VP) cerebrospinal fluid (CSF) shunting, worsens the prognosis substantially. Thus, VP CSF shunting does not seem to be the optimal therapy for hydrocephalic children with plasminogen deficiency. We add two cases to the literature, and, on the base of our experience, we propose a management strategy for the hydrocephalus. We report the case history of two children with plasminogen deficiency and associated hydrocephalus. Both children initially were treated with VP shunts and had a very similar clinical course with multiple shunt malfunctions due to nonabsorption by the peritoneum. In the first child, the attempt to treat the hydrocephalus with a ventriculoatrial (VA) shunt failed due to catheter thrombosis. Finally, a ventriculocholecystic shunt was placed in both children, which worked well. In patients with plasminogem deficiency and associated hydrocephalus, special care must be taken in the management of hydrocephalus. The absorptive capacity of the peritoneum is reduced by pseudomembrane formation, which results in VP shunt malfunction. The plasminogen deficiency results in early thrombus formation if atrial catheters are used. Therefore, the authors believe that ventriculocholecystic shunting should be considered early on in the course of the disease.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Cerebral Edema ll: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Increased Intracranial Pressure l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

